Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
VEGFR1/Flt-1 Antibody (EWC) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody has been used in 2 publications
Supplier: Novus Biologicals NB600100420UG
Description
VEGFR1/Flt-1 Monoclonal specifically detects VEGFR1/Flt-1 in Human, Mouse samples. It is validated for Western Blot, ELISA, Immunocytochemistry/Immunofluorescence, In vivo assay.Specifications
| VEGFR1/Flt-1 | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1-10 ug/ml, ELISA 1.5-8 ug/ml, Immunocytochemistry/Immunofluorescence 2-10 ug/ml, In vivo assay | |
| P17948 | |
| FLT1 | |
| human recombinant Cadherin-17 extra cellular domain | |
| 20 μg | |
| Angiogenesis, Cancer, HIF Target Genes, Hypoxia, Stem Cell Markers | |
| 2321 | |
| Reconstitute the antibody with 500 ul sterile PBS and the final concentration is 200 ug/ml. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG1 |
| In vitro Assay, Immunofluorescence, ELISA, Immunocytochemistry, Western Blot | |
| Flt-1/EWC | |
| Unconjugated | |
| PBS (pH 7.4) with No Preservative | |
| EC 2.7.10, EC 2.7.10.1, FLT, FLT-1, Fms-like tyrosine kinase 1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascularpermeability factor receptor), FRT, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, vascular endothelial growth factor receptor 1, Vascular permeability factor receptor, VEGFR1, VEGFR-1 | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| The monoclonal will detect native and denaturated human VEGFR-1/ Flt-1 in ELISA experiments and on the surface of different human cell types. The will also detect mouse Flt-1. | |
| Human, Mouse | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction